Does PEMBROLIZUMAB Cause Myelosuppression? 821 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 821 reports of Myelosuppression have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 1.0% of all adverse event reports for PEMBROLIZUMAB.
821
Reports of Myelosuppression with PEMBROLIZUMAB
1.0%
of all PEMBROLIZUMAB reports
60
Deaths
310
Hospitalizations
How Dangerous Is Myelosuppression From PEMBROLIZUMAB?
Of the 821 reports, 60 (7.3%) resulted in death, 310 (37.8%) required hospitalization, and 43 (5.2%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 821 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which PEMBROLIZUMAB Alternatives Have Lower Myelosuppression Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G